Aberdeen Group plc Acquires 7,015 Shares of Veeva Systems Inc. $VEEV

Key Points

• Aberdeen Group plc increased its stake in Veeva Systems by 10.1%, acquiring an additional 7,015 shares, bringing their total holdings to 76,764 shares, valued at approximately $22.1 million.
• Veeva Systems reported a quarterly EPS of $1.26, missing analysts' expectations of $1.90, despite achieving revenue of $789.08 million, exceeding projections.
• Multiple analysts have increased their price targets for Veeva Systems, with targets ranging from $295.00 to $330.00, indicating a generally favorable outlook for the stock.

Aberdeen Group plc grew its holdings in shares of Veeva Systems Inc. (NYSE:VEEV - Free Report) by 10.1% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 76,764 shares of the technology company's stock after buying an additional 7,015 shares during the quarter. Aberdeen Group plc's holdings in Veeva Systems were worth $22,106,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Abound Financial LLC bought a new stake in Veeva Systems during the 1st quarter worth about $25,000. ORG Partners LLC bought a new stake in Veeva Systems during the 1st quarter worth about $26,000. Golden State Wealth Management LLC increased its stake in shares of Veeva Systems by 152.9% during the 1st quarter. Golden State Wealth Management LLC now owns 129 shares of the technology company's stock worth $30,000 after purchasing an additional 78 shares during the last quarter. Wayfinding Financial LLC acquired a new position in shares of Veeva Systems during the 1st quarter worth about $32,000. Finally, Legacy Investment Solutions LLC acquired a new position in shares of Veeva Systems during the 2nd quarter worth about $32,000. 88.20% of the stock is owned by institutional investors.

Veeva Systems Stock Performance

Shares of VEEV opened at $286.54 on Tuesday. Veeva Systems Inc. has a 52 week low of $201.54 and a 52 week high of $310.50. The firm has a market cap of $46.97 billion, a P/E ratio of 58.84, a price-to-earnings-growth ratio of 2.22 and a beta of 0.98. The firm's 50-day simple moving average is $282.93 and its 200 day simple moving average is $265.62.

Veeva Systems (NYSE:VEEV - Get Free Report) last announced its quarterly earnings results on Wednesday, August 27th. The technology company reported $1.26 EPS for the quarter, missing analysts' consensus estimates of $1.90 by ($0.64). Veeva Systems had a net margin of 27.29% and a return on equity of 13.72%. The company had revenue of $789.08 million during the quarter, compared to analyst estimates of $768.49 million. During the same quarter last year, the company posted $1.62 EPS. The firm's quarterly revenue was up 16.7% on a year-over-year basis. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. As a group, equities analysts forecast that Veeva Systems Inc. will post 4.35 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Evercore ISI boosted their price objective on shares of Veeva Systems from $285.00 to $295.00 and gave the stock an "in-line" rating in a research note on Thursday, August 28th. Mizuho boosted their price objective on shares of Veeva Systems from $295.00 to $325.00 and gave the stock an "outperform" rating in a research note on Friday, August 29th. KeyCorp boosted their price objective on shares of Veeva Systems from $285.00 to $325.00 and gave the stock an "overweight" rating in a research note on Monday, July 14th. Morgan Stanley boosted their price objective on shares of Veeva Systems from $210.00 to $222.00 and gave the stock an "underweight" rating in a research note on Thursday, August 28th. Finally, JPMorgan Chase & Co. upgraded shares of Veeva Systems from a "neutral" rating to an "overweight" rating and boosted their price objective for the stock from $290.00 to $330.00 in a research note on Monday, September 8th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, Veeva Systems has an average rating of "Moderate Buy" and an average target price of $307.58.

Insider Buying and Selling at Veeva Systems

In other Veeva Systems news, insider Eleni Nitsa Zuppas sold 6,000 shares of the business's stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $306.62, for a total value of $1,839,720.00. Following the completion of the sale, the insider owned 25,325 shares of the company's stock, valued at $7,765,151.50. The trade was a 19.15% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Jonathan Faddis sold 720 shares of the business's stock in a transaction dated Monday, October 6th. The shares were sold at an average price of $298.12, for a total transaction of $214,646.40. Following the completion of the sale, the senior vice president directly owned 7,868 shares of the company's stock, valued at $2,345,608.16. This represents a 8.38% decrease in their position. The disclosure for this sale can be found here. Insiders sold 24,665 shares of company stock valued at $7,438,000 in the last quarter. Company insiders own 10.30% of the company's stock.

Veeva Systems Company Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.

Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.